Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Could these be considered "orphan" indications?

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free

Reply New Message

Prev Message Back To Forum Threaded View Next Message

someconcerns

Rank: Mail Room [?]

Points: 213 [?]

Votes: 6 Score: 3.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Could these be considered "orphan" indications?

in response to

Re: Could these be considered "orphan" indications?

by

posted on Feb 14, 2017 08:49PM

Log in to use the IP Check tool ^[?]

And I see another Priority Review Voucher which sold for $350mm USD.

https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=9&cad=rja&uact=8&ved=0ahUKEwiM-K_Y-5DSAhXH7IMKHcDWCTkQFghIMAg&url=http%3A%2F%2Fwww.wsj.com%2Farticles%2Fsanofi-regenerons-alirocumab-shows-promise-in-phase-iii-trials-1406738434&usg=AFQjCNHLUIUVnaoMGb6P1XeNoTbMQ7oUdw&sig2=QpkJw8q4_g6NA1Xh_7cazQ

Loading...

Loading...

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Share

Share

Share

Please to post a reply